Total Payments
$4,305
2024 Payments
$18.34
Companies
20
Transactions
282
Medicare Patients
1,726
Medicare Billing
$157,083
Payment Breakdown by Category
Food & Beverage$3,997 (92.8%)
Other$187.00 (4.3%)
Education$120.97 (2.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,997 | 275 | 92.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $187.00 | 4 | 4.3% |
| Education | $120.97 | 3 | 2.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $968.03 | 80 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $763.47 | 49 | $0 (2023) |
| Lilly USA, LLC | $576.71 | 36 | $0 (2023) |
| Amgen Inc. | $381.47 | 24 | $0 (2023) |
| SANOFI-AVENTIS U.S. LLC | $357.83 | 17 | $0 (2023) |
| Teva Pharmaceuticals USA, Inc. | $279.26 | 11 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $187.71 | 14 | $0 (2019) |
| PFIZER INC. | $163.31 | 11 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $127.80 | 8 | $0 (2023) |
| AbbVie Inc. | $117.78 | 7 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $18.34 | 1 | Novo Nordisk Inc ($18.34) |
| 2023 | $677.39 | 40 | Lilly USA, LLC ($153.75) |
| 2022 | $358.57 | 23 | Amgen Inc. ($84.46) |
| 2021 | $354.59 | 17 | SANOFI-AVENTIS U.S. LLC ($122.00) |
| 2020 | $85.26 | 6 | AstraZeneca Pharmaceuticals LP ($30.20) |
| 2019 | $695.94 | 39 | Lilly USA, LLC ($192.30) |
| 2018 | $905.68 | 65 | Novo Nordisk Inc ($298.67) |
| 2017 | $1,210 | 91 | Novo Nordisk Inc ($285.25) |
All Payment Transactions
282 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/25/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.34 | General |
| Category: Diabetes | ||||||
| 11/08/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: Inflammation | ||||||
| 11/06/2023 | Shield Therapeutics Inc | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $19.69 | General |
| Category: Hematology | ||||||
| 10/13/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $13.30 | General |
| Category: RESPIRATORY | ||||||
| 10/11/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $16.68 | General |
| Category: Obesity | ||||||
| 09/19/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.06 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/14/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $15.03 | General |
| Category: Diabetes | ||||||
| 09/13/2023 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $14.50 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 08/30/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.56 | General |
| Category: Diabetes | ||||||
| 08/15/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.19 | General |
| Category: Inflammation | ||||||
| 07/14/2023 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.97 | General |
| Category: Diabetes | ||||||
| 06/20/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.89 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/16/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $20.99 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/09/2023 | Novo Nordisk Inc | Wegovy (Drug), Saxenda | Food and Beverage | In-kind items and services | $16.17 | General |
| Category: Obesity | ||||||
| 05/03/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $21.59 | General |
| Category: Inflammation | ||||||
| 05/01/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $28.15 | General |
| Category: Cardio-renal | ||||||
| 04/26/2023 | Shield Therapeutics Inc | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $13.15 | General |
| Category: Hematology | ||||||
| 04/24/2023 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.07 | General |
| Category: Diabetes | ||||||
| 04/13/2023 | Lilly USA, LLC | TRULICITY (Drug), MOUNJARO | Food and Beverage | In-kind items and services | $19.72 | General |
| Category: Diabetes | ||||||
| 04/05/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $21.17 | General |
| Category: NEUROSCIENCE | ||||||
| 04/04/2023 | Lilly USA, LLC | TRULICITY (Drug), MOUNJARO | Food and Beverage | In-kind items and services | $19.93 | General |
| Category: Diabetes | ||||||
| 03/30/2023 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Biological) | Food and Beverage | In-kind items and services | $14.86 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 03/16/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.39 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/13/2023 | Novo Nordisk Inc | Saxenda (Drug), Wegovy | Food and Beverage | In-kind items and services | $19.17 | General |
| Category: Obesity | ||||||
| 03/10/2023 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $16.48 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 456 | 662 | $126,586 | $39,524 |
| 2022 | 8 | 416 | 597 | $122,007 | $40,217 |
| 2021 | 8 | 399 | 628 | $112,900 | $40,308 |
| 2020 | 9 | 455 | 696 | $111,530 | $37,035 |
Total Patients
1,726
Total Services
2,583
Medicare Billing
$157,083
Procedure Codes
32
All Medicare Procedures & Services
32 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 94 | 238 | $50,987 | $14,687 | 28.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 51 | 101 | $31,310 | $9,355 | 29.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Facility | 2023 | 72 | 72 | $21,996 | $8,858 | 40.3% |
| 99497 | Advance care planning, first 30 minutes | Facility | 2023 | 81 | 82 | $14,678 | $4,021 | 27.4% |
| G0446 | Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | Facility | 2023 | 76 | 76 | $5,092 | $1,715 | 33.7% |
| G0444 | Annual depression screening, 5 to 15 minutes | Facility | 2023 | 71 | 71 | $1,775 | $631.19 | 35.6% |
| 99406 | Smoking and tobacco use intensive counseling, 4-10 minutes | Facility | 2023 | 11 | 22 | $748.00 | $256.08 | 34.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 114 | 263 | $56,282 | $16,174 | 28.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Facility | 2022 | 76 | 76 | $20,140 | $9,314 | 46.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 47 | 72 | $22,320 | $7,415 | 33.2% |
| 99497 | Advance care planning, first 30 minutes | Facility | 2022 | 77 | 78 | $13,962 | $4,260 | 30.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 15 | 15 | $4,395 | $1,344 | 30.6% |
| G0446 | Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | Facility | 2022 | 57 | 57 | $3,819 | $1,325 | 34.7% |
| 99406 | Smoking and tobacco use intensive counseling, 4-10 minutes | Facility | 2022 | 15 | 21 | $714.00 | $250.23 | 35.0% |
| G0444 | Annual depression screening, 15 minutes | Facility | 2022 | 15 | 15 | $375.00 | $135.33 | 36.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 112 | 316 | $66,338 | $22,022 | 33.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Facility | 2021 | 79 | 79 | $20,935 | $10,073 | 48.1% |
| 99497 | Advance care planning by the physician or other qualified health care professional, first 30 minutes | Facility | 2021 | 83 | 83 | $14,721 | $4,428 | 30.1% |
| G0446 | Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | Facility | 2021 | 67 | 67 | $4,489 | $1,587 | 35.4% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 12 | 12 | $3,516 | $1,143 | 32.5% |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | Facility | 2021 | 17 | 20 | $1,320 | $473.80 | 35.9% |
| 99406 | Smoking and tobacco use intermediate counseling, greater than 3 minutes up to 10 minutes | Facility | 2021 | 13 | 35 | $1,196 | $432.95 | 36.2% |
| G0444 | Annual depression screening, 15 minutes | Facility | 2021 | 16 | 16 | $385.00 | $147.52 | 38.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 121 | 313 | $56,104 | $17,387 | 31.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Facility | 2020 | 87 | 87 | $23,055 | $9,307 | 40.4% |
About Dr. Yekaterina Brown, DO
Dr. Yekaterina Brown, DO is a Family Medicine healthcare provider based in Glen Dale, West Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/09/2008. The National Provider Identifier (NPI) number assigned to this provider is 1588831523.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Yekaterina Brown, DO has received a total of $4,305 in payments from pharmaceutical and medical device companies, with $18.34 received in 2024. These payments were reported across 282 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($3,997).
As a Medicare-enrolled provider, Brown has provided services to 1,726 Medicare beneficiaries, totaling 2,583 services with total Medicare billing of $157,083. Data is available for 4 years (2020–2023), covering 32 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Glen Dale, WV
- Active Since 05/09/2008
- Last Updated 04/06/2022
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1588831523
Products in Payments
- FARXIGA (Drug) $680.15
- Victoza (Drug) $382.32
- TRULICITY (Drug) $347.43
- Ozempic (Drug) $254.72
- Tresiba (Drug) $155.03
- TOUJEO (Biological) $154.94
- Aimovig (Biological) $131.47
- Prolia (Biological) $115.28
- XARELTO (Drug) $107.10
- UBRELVY (Drug) $101.30
- AJOVY (Drug) $85.49
- SOLIQUA (Drug) $84.69
- JARDIANCE (Drug) $84.23
- TRADJENTA (Drug) $84.11
- INVOKANA (Drug) $80.61
- Otezla (Drug) $75.06
- TOUJEO (Drug) $74.63
- EMGALITY (Drug) $74.48
- V-GO (Device) $69.53
- CHANTIX (Drug) $69.04
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.